2017 News Releases

2017 News Releases

Illinois Surgical Quality Improvement Collaborative and Pacira Pharmaceuticals, Inc. Announce Collaboration to Minimize Opioid Exposure for Postsurgical Patients
12/14/17
Pacira Pharmaceuticals to Present at the 2017 BMO Capital Markets Prescriptions for Success Healthcare Conference
12/08/17
Pacira Announces Promotions of Scott Braunstein, MD, to Chief Operating Officer and Richard Scranton, MD, to Chief Scientific Officer
12/07/17
Cancer Treatment Centers of America® Teams with Pacira Pharmaceuticals, Inc. on Innovative Collaboration to Educate Physicians and Patients about Responsible Opioid Use
11/29/17
Pacira Announces FDA Advisory Committee Meeting to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
11/14/17
Pacira Pharmaceuticals to Present at Two November Healthcare Conferences
11/09/17
Pacira Pharmaceuticals, Inc. Reports Third Quarter 2017 Financial Results
11/08/17
Pacira Pharmaceuticals Announces Timing for Third Quarter 2017 Financial Results Webcast and Conference Call
10/31/17
Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement
10/25/17
Pacira Pharmaceuticals Announces FDA Acceptance of sNDA for EXPAREL as a Nerve Block to Produce Regional Analgesia
10/18/17
Pacira Pharmaceuticals CEO to Testify at White House Opioid Crisis Commission Meeting
09/27/17
New Research: Overprescribing of Postsurgical Opioids Poses a Serious Threat to Patients and their Communities; Women Undergoing Surgery are at Greatest Risk
09/26/17
Pacira Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
09/20/17
Pacira Pharmaceuticals, Aetna, and the American Association of Oral and Maxillofacial Surgeons Join Together in a Program to Reduce Opioid Exposure for Patients Undergoing Wisdom Tooth Extraction
09/13/17
Pacira Pharmaceuticals Announces Multiple EXPAREL Data Presentations at the Upcoming New York School of Regional Anesthesia Annual Fall Symposium
09/06/17
Pacira Pharmaceuticals to Present at the 2017 H.C. Wainwright 19th Annual Global Investment Conference
09/05/17
Pacira Pharmaceuticals to Present at the 2017 Wells Fargo Healthcare Conference
08/31/17
Pacira Pharmaceuticals to Present at the 2017 Wedbush Pacgrow Healthcare Conference
08/09/17
Pacira Pharmaceuticals, Inc. Reports Second Quarter 2017 Financial Results
08/02/17
Pacira Announces Publication of Phase 4 Study of EXPAREL in Patients Undergoing Total Knee Replacement in The Journal of Arthroplasty
07/26/17
Pacira Pharmaceuticals Announces Timing for Second Quarter 2017 Financial Results Webcast and Conference Call
07/25/17
Pacira Announces Topline Phase 3 Results for EXPAREL® as a Single-dose Nerve Block
07/25/17
Pacira Pharmaceuticals Appoints Mark I. Froimson, M.D., to Board of Directors
06/15/17
Pacira Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
06/14/17
Pacira Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
06/01/17
Pacira Pharmaceuticals Announces Resignation of James Scibetta
05/23/17
Pacira Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference
05/10/17
Pacira Pharmaceuticals, Inc. Reports First Quarter 2017 Financial Results
05/04/17
New Research Shows Vast Majority of Oral Surgery Patients Would Choose Non-opioid Medication to Treat Postsurgical Pain if Given the Option
05/03/17
Pacira Pharmaceuticals Announces Timing for First Quarter 2017 Financial Results Webcast and Conference Call
04/27/17
Pacira Pharmaceuticals, Inc. to Present at the Needham Healthcare Conference
04/03/17
Trinity Health and Pacira Pharmaceuticals Announce Collaboration to Decrease Opioid Use Nationwide
03/16/17
Phase 4 Study Shows EXPAREL® Versus an Active Comparator Significantly Reduces Opioid Consumption and Postsurgical Pain in Patients Undergoing Total Knee Arthroplasty
03/14/17
Pacira Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
03/13/17
Pacira Pharmaceuticals Announces Pricing of $300 Million Aggregate Principal Amount of 2.375% Convertible Senior Notes due 2022
03/07/17
Pacira Pharmaceuticals Announces Proposed Offering of $300 Million Aggregate Principal Amount of Convertible Senior Notes
03/06/17
Pacira Pharmaceuticals Reports 2016 Financial Results and Provides Business Update
03/01/17
Pacira Pharmaceuticals Announces Timing for 2016 Financial Results Webcast and Conference Call
02/16/17
Pacira Pharmaceuticals, Inc. to Present at the 2017 RBC Capital Markets’ Healthcare Conference
02/15/17
Pacira Pharmaceuticals Announces Collaboration with DePuy Synthes to Support Promotion, Education and Training of EXPAREL® in Orthopedics
01/25/17
Pacira Pharmaceuticals Reports Preliminary 2016 Revenues of $276.4 Million
01/06/17
Pacira Pharmaceuticals, Inc. to Present at the 35th Annual J.P. Morgan Healthcare Conference
01/03/17